JP2021513865A5 - - Google Patents
Info
- Publication number
- JP2021513865A5 JP2021513865A5 JP2020544642A JP2020544642A JP2021513865A5 JP 2021513865 A5 JP2021513865 A5 JP 2021513865A5 JP 2020544642 A JP2020544642 A JP 2020544642A JP 2020544642 A JP2020544642 A JP 2020544642A JP 2021513865 A5 JP2021513865 A5 JP 2021513865A5
- Authority
- JP
- Japan
- Prior art keywords
- streptococcus
- group
- amino acid
- modified lysin
- lysin polypeptide
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635515P | 2018-02-26 | 2018-02-26 | |
| US62/635,515 | 2018-02-26 | ||
| PCT/US2019/019638 WO2019165454A1 (en) | 2018-02-26 | 2019-02-26 | Modified plyss2 lysins and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021513865A JP2021513865A (ja) | 2021-06-03 |
| JP2021513865A5 true JP2021513865A5 (https=) | 2022-02-09 |
| JPWO2019165454A5 JPWO2019165454A5 (https=) | 2022-02-09 |
Family
ID=67687985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544642A Pending JP2021513865A (ja) | 2018-02-26 | 2019-02-26 | 修飾ＰｌｙＳｓ２溶解素及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210032294A1 (https=) |
| EP (1) | EP3758738A4 (https=) |
| JP (1) | JP2021513865A (https=) |
| KR (1) | KR20200124724A (https=) |
| CN (1) | CN112118861A (https=) |
| AU (1) | AU2019224160A1 (https=) |
| BR (1) | BR112020017219A2 (https=) |
| CA (1) | CA3092109A1 (https=) |
| IL (1) | IL276807A (https=) |
| MX (1) | MX2020008860A (https=) |
| RU (1) | RU2020128276A (https=) |
| WO (1) | WO2019165454A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020210691A1 (en) * | 2019-04-11 | 2020-10-15 | Contrafect Corporation | Method of treating and preventing bone and joint infections |
| US20230277632A1 (en) * | 2020-05-19 | 2023-09-07 | Contrafect Corporation | MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE AGAINST GRAM-POSITIVE BACTERIA |
| WO2023049747A1 (en) * | 2021-09-22 | 2023-03-30 | Elanco Us Inc. | Streptococcus suis lytic enzyme compositions and methods of use thereof |
| WO2023081691A1 (en) * | 2021-11-04 | 2023-05-11 | Contrafect Corporation | Method of treating and preventing bone and joint infections |
| CN115851689A (zh) * | 2022-08-09 | 2023-03-28 | 中南民族大学 | 一种嵌合裂解酶PlySs2E-V12C及其应用、重组质粒和重组菌株 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2699253T3 (en) * | 2011-04-21 | 2018-07-16 | Univ Rockefeller | STREPTOCOCCUS BACTERYPHAGIC LYSINES FOR THE DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIES |
| DK3085777T3 (da) * | 2011-05-04 | 2020-02-03 | Micreos Human Health Bv | Polypeptid |
| RU2018121290A (ru) * | 2012-05-09 | 2019-03-06 | Контрафект Корпорейшн | Комбинации лизина бактериофага и антибиотика против грам-положительных бактерий |
| BR112014027818B1 (pt) * | 2012-05-09 | 2023-03-28 | Contrafect Corporation | Usos de composições compreendendo polipeptídeo de lisina para prevenção, ruptura ou tratamento de um biofilme bacteriano |
| CN104073478A (zh) * | 2014-06-13 | 2014-10-01 | 上海交通大学 | 杀灭革兰氏阳性菌的酶抗生素及其制备、用途 |
| CN104211781A (zh) * | 2014-09-04 | 2014-12-17 | 北京纳百景弈生物科技有限公司 | 金黄色葡萄球菌裂解蛋白的制备方法及其应用 |
| EP3454888B1 (en) * | 2016-05-12 | 2021-02-24 | Contrafect Corporation | Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides |
-
2019
- 2019-02-26 BR BR112020017219-7A patent/BR112020017219A2/pt not_active IP Right Cessation
- 2019-02-26 US US16/975,321 patent/US20210032294A1/en not_active Abandoned
- 2019-02-26 AU AU2019224160A patent/AU2019224160A1/en not_active Abandoned
- 2019-02-26 MX MX2020008860A patent/MX2020008860A/es unknown
- 2019-02-26 EP EP19757130.0A patent/EP3758738A4/en active Pending
- 2019-02-26 CA CA3092109A patent/CA3092109A1/en active Pending
- 2019-02-26 WO PCT/US2019/019638 patent/WO2019165454A1/en not_active Ceased
- 2019-02-26 CN CN201980027962.7A patent/CN112118861A/zh active Pending
- 2019-02-26 RU RU2020128276A patent/RU2020128276A/ru unknown
- 2019-02-26 JP JP2020544642A patent/JP2021513865A/ja active Pending
- 2019-02-26 KR KR1020207027681A patent/KR20200124724A/ko not_active Ceased
-
2020
- 2020-08-19 IL IL276807A patent/IL276807A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513865A5 (https=) | ||
| Al Atya et al. | Anti-MRSA activities of enterocins DD28 and DD93 and evidences on their role in the inhibition of biofilm formation | |
| Mathur et al. | Fighting biofilms with lantibiotics and other groups of bacteriocins | |
| JP2022058682A5 (https=) | ||
| RU2020128276A (ru) | МОДИФИЦИРОВАННЫЕ ЛИЗИНЫ PlySs2 И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ | |
| Gibbons et al. | The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet (K) determinant | |
| RU2014149351A (ru) | Комбинации лизина бактериофага и антибиотика против грам-положительных бактерий | |
| RU2018102796A (ru) | Предотвращение, разрушение и обработка биопленки лизином бактериофага | |
| JP2021519083A5 (https=) | ||
| Fan et al. | Antibacterial activity of the recombinant antimicrobial peptide Ib-AMP4 from Impatiens balsamina and its synergy with other antimicrobial agents against drug resistant bacteria | |
| Wladyka et al. | Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91 | |
| EP3164146B1 (en) | Acinetobacter lysins | |
| RU2018107249A (ru) | Применение лизина для восстановления/увеличения антибактериальной активности антибиотиков в присутствии легочного сурфактанта, который ингибирует указанные антибиотики | |
| Basi-Chipalu et al. | A review on characterization, applications and structure-activity relationships of Bacillus species-produced bacteriocins | |
| WO2009111064A3 (en) | Minocycline compounds and methods of use thereof | |
| Hwang et al. | Engineering microbes for targeted strikes against human pathogens | |
| Rahimzadeh et al. | Endolysins of bacteriophages as an anti-methicillin resistant staphylococcus aureus infection in children: a narrative review | |
| WO2010041970A3 (en) | Antibacterial phage peptides and methods of use thereof | |
| MX2021015563A (es) | Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes. | |
| Chen et al. | Engineered endolysin of Klebsiella pneumoniae phage is a potent and broad-spectrum bactericidal agent against “ESKAPEE” pathogens | |
| Abraham et al. | A tick antivirulence protein potentiates antibiotics against Staphylococcus aureus | |
| JP2017533177A5 (https=) | ||
| HRP20200195T1 (hr) | Antibiotske terapije na bazi peptida porijeklom od vodenog bivola | |
| JP2020527164A (ja) | グラム陰性病原体に対する抗微生物活性を示す抗微生物ペプチド及びその混合物 | |
| JPWO2019165454A5 (https=) |